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Abstract
Background: Timely and enduring access to antiretroviral therapy (ART) by HIV-infected individuals has been
shown to substantially reduce HIV transmission risk, HIV-related morbidity and mortality. However, there is evidence
that in addition to limited supply of antiretrovirals (ARVs) and linkage to ART in many low-income countries, HIV+
persons often encounter barriers in accessing ART-related services even in contexts where these services are freely
available. In Ghana, limited research evidence exists regarding the barriers HIV+ persons already linked to ART face.
This paper explores ART access–related barriers that HIV+ persons linked to care in southern Ghana face.
Methods: A mixed method study design, involving a cross-sectional survey and qualitative in-depth interviews, was
conducted to collect data from four healthcare providers and a total of 540 adult HIV+ persons receiving ART at
four treatment centres in Ghana. We used univariate analysis to generate descriptive tabulations for key variables
from the survey. Data from qualitative in-depth interviews were thematically analysed. Results from the survey and
in-depth interviews were brought together to illuminate the challenges of the HIV+ persons.
Results: All (100%) the HIV+ persons interviewed were ARV-exposed and linked to ART. Reasons for taking ARVs
ranged from beliefs that they will suppress the HIV virus, desire to maintain good health and prolong life, and
desire to prevent infection in unborn children, desire both to avoid death and to become good therapeutic citizens
(abide by doctors’ advice). Despite this, more than half of the study participants (63.3%) reported seven major
factors as barriers hindering access to ART. These were high financial costs associated with accessing and receiving
ART (26%), delays associated with receiving care from treatment centres (24%), shortage of drugs and other
commodities (23%), stigma (8.8%), fear of side effects of taking ARVs (7.9%), job insecurity arising from regular leave
of absence to receive ART (5.3%), and long distance to treatment centres (4.9%).
Conclusions: The results in this study suggest that efforts to provide and scale-up ART to all HIV+ persons must be
accompanied by interventions that address structural and individual level access barriers.
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Background
Globally, timely access to antiretrovirals (ARVs) and
antiretroviral therapy (ART) by people living with HIV
(PLH) has been shown to substantially reduce morbidity
and mortality, reduce HIV transmission risk even with
modest ART coverage of the HIV-infected population
and imperfect ART adherence, improve employment
rates to levels prior to HIV infection, as well as improve
the overall quality of life of PLH [1–5]. Indeed, one re-
cent report detailed the benefits of ART as follows: ART
averted 5.5 million deaths in low- and middle-income
countries between 1995 and 2012, with Sub-Saharan
Africa accounting for most of those lives saved; ART re-
duced the risk of HIV transmission by up to 96% and
the risk of tuberculosis infection among PLH by 65% [6].
Also, spending on ART generated economic returns of
double or more than the initial investment, while working-
age adults living with HIV can return to work earlier when
they receive treatment, boosting labour productivity and
reducing hardship among affected households [6].
These benefits notwithstanding, durable access to ART
remains a crucial problem for PLH in resources-limited
settings, and studies continue to highlight the challenges
in ensuring effective HIV continuum of care (i.e. Propor-
tion who know their diagnosis of HIV, of them how many
engaged in HIV care, of them how many prescribed ART,
retained on ART, and of them proportion with viral load
undetectable) [4–7]. There is evidence that in addition to
limited supply of ARVs and ART in many low-income
countries, PLH often encounter challenges in accessing
ARVs and ART services even in contexts where these ser-
vices are freely available [4–7]. For example, although the
number of people receiving ART continues to rise in
Africa, it is estimated that approximately three-quarters of
adults living with HIV in sub-Saharan Africa have no
access to ART [6, 8]. Of the 21.2 million people in Africa
eligible for ART in 2013 based on the 2013 WHO guide-
lines for example, only 7.6 million people were receiving
HIV treatment [6]. In the case of Ghana, ART for PLH
was piloted in June 2003 [9]. The Ghana National HIV/
STI Control Programme of the Ghana Health Service re-
ported that by December 2007, only about 13,429 out of
an estimated 70,000 HIV+ persons who needed ART had
been put on treatment [10]. As at November 2009 the
number of HIV+ persons who were receiving ART rose to
about 31,400 [11]. Despite this laudable achievement in
Ghana, about 70% of PLHIV in need of ART did not have
access in 2009 [11].
Gaps in testing, delays in seeking/accessing treatment
and retention are acknowledged weaknesses the HIV
prevention-care continuum in Ghana. Successful attain-
ment of treatment cascade steps has not been fully
achieved. For example, HIV counseling & testing in the
general adult population remains low, within the range of
4–10% [11]. Of note, while still lower than the optimal
level, counseling and testing among pregnant women is up
to 67% as of 2011. Despite these gains, about half of eligible
people living with HIV received ART in 2011 [11]. How-
ever, data on adherence to ART regimens is poor likely due
to the difficulties in linking HIV+ persons to treatment as
well as retention into care. Reliable estimates on achieve-
ment of the key HIV care cascade steps have not been
widely reported in Ghana. The corresponding author of this
paper and his team are currently implementing a study to
understand the barriers as well as facilitators to achieving
the HIV treatment and prevention care cascade in Ghana.
In the international research literature, a number of
barriers have been identified as hindering access to ART.
Limited trained health staff [12–14], lack of comfortable
hospital facilities to provide ART [15, 16], shortages and
unavailability of ART in certain places especially in low-
income settings [17, 18], high costs, including travel, op-
portunity and social costs associated with ART [7, 19],
are some of the most commonly cited barriers HIV+
persons face in accessing ART. Fear of side effects [20],
fear of stigma and discrimination [14, 21] and lack of ad-
equate social support [22] have also been reported as
formidable barriers hindering access to ART.
While there is growing recognition in both inter-
national and local policy and empirical research litera-
ture that PLH may encounter barriers in accessing ART
services even in contexts where these services are freely
available, there is limited research in Ghana that asks
PLH about the barriers that PLH already linked to ART
face. For example, one study in Ghana suggested that
shortage of ARVs and differential pricing policy between
private and public health facilities - the ART services in
private health facilities attract a fee of about $30 per
month, ten times greater than the public rate - hindered
access to ART [11]. Another study suggested that long
waiting time before care is received in ART clinics dis-
couraged PLH from accessing ART in Ghana [9]. While
these pioneering studies in Ghana have highlighted some
of the barriers to accessing ART, they nevertheless have
not paid sufficient attention to the perspectives of PLH.
Understanding the perspectives of PLH in relation to
the barriers they face in accessing ART could however
form the basis for implementing contextually relevant
programmatic initiatives to both redress these chal-
lenges and better improve access and adherence to
ART [14]. This paper presents and discusses access –
related barriers that HIV+ persons already linked to
ART in southern Ghana face.
Methods
Study design
This study forms part of a larger original study that was
conducted to examine non-prescription drug use among
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HIV+ persons on ART, adherence to ART, and barriers
HIV+ persons face accessing ART in Ghana. A mixed
method study design, involving a cross-sectional survey
and qualitative in-depth interviews, was conducted to
collect data from healthcare providers and a total of 540
adult HIV+ persons receiving ART at four treatment
centres in the Eastern and Greater Accra regions of
Ghana. For the purposes of the current paper, we focus
on, and report findings from both the survey and quali-
tative interviews that are related to the barriers HIV+
persons face accessing ART.
Study sites
Empirical research was conducted at four health facilities
in southern Ghana where ART is offered to HIV-
infected clients. These health facilities are the Fevers
Unit of the Korle Bu Teaching Hospital and the Tema
General Hospital (both in the Greater Accra region of
Ghana), and the Atua Government Hospital, and St
Martins de Porres Hospital in the Eastern region of
Ghana. The Korle Bu Teaching Hospital is one of the
tertiary hospitals in southern part of Ghana. The Fevers
unit is affiliated to the department of medicine. This unit
treats cases such as measles, rabies, chicken pox, tetanus
and chronic diarrhoea among others. At the time of the
study, the Fevers Unit of the Korle Bu Teaching Hospital
had about 6000 patients who were on ART. Tema Gen-
eral Hospital sees about 1500 HIV+ clients who are en-
rolled on ART. The Atua Government Hospital and St.
Martins de Porres Hospital were the first PMTCT sites
in Ghana. The Atua Government hospital and the St.
Martins de Porres hospital have about 4800 and 4000
HIV+ clients on ART respectively.
Study participants
The study participants comprised adult HIV+ persons
receiving ART at the Korle Bu Teaching Hospital, the
Tema General Hospital, the Atua Government Hospital
and the St. Martins de Porres Hospital. In addition,
healthcare providers (i.e. Nurse Prescribers who manage
the ART clinics) at the four study sites were interviewed.
Sample size estimation and sampling
The sample size for the survey component of the study
was determined using Statcalc in Epi Info 2000 package.
The exact number of HIV+ persons on ART who may
be experiencing our primary outcome of interest (i.e.
face barriers accessing ART) is unknown in the four
study sites. Based on previous literature [9, 14] we esti-
mated that 50% of the total number of HIV+ persons on
ART from the four study sites face one barrier or the
other accessing ART. With an alpha of 0.05 and a statis-
tical power of 90%, 434 clients were computed as the
minimum sample needed to assess the barriers HIV+
persons face accessing ART from the four treatment
centres. To account for non-response and errors in data
recording, this sample size was further increased by 20%.
The final sample size was thus 434 + 87 = 521. However,
being part of a larger study with an overall sample size
of 540, all of the 540 PLH were used for this analysis.
Prior to sampling, the probability proportional to size
weighting procedure was employed in the allotment of
the HIV+ persons to the four study sites. Study partici-
pants were selected using systematic random sampling
procedures. To do this, the master list of ART clients at
each facility served as the site-specific sampling frame.
The sampling interval (n) for each site was derived by
dividing the total number of participants on the register
by the required sample at each site.
For the qualitative component of the study, we pur-
posively selected four ART In-charges (one each from
the four study sites) for in-depth interviewing. These
ART In-charges are healthcare providers (usually Nurse
Prescribers) who manage the ART clinics at their re-
spective hospitals. Therefore, not only were they
knowledgeable in the workings of ART, but also they
knew most of the HIV+ persons who were on ART in
their respective clinics.
Study instruments
For the survey component of the study, questionnaires
were the data collection instruments. The questionnaire
had closed-ended questions as well as open-ended ques-
tions. The questionnaires were designed to elicit infor-
mation on the various aspects of ART, including the
socio-demographic characteristics of ART clients, desire
and motivation to be on ART and barriers encountered
in accessing ART. Apriori identified potential barriers to
accessing ART, which formed part of the questionnaire,
included periodic shortages of ARVs, cost of ARVs, side
effects associated with ARVs, and perceived efficacy of
alternative medications.
For the in-depth interviews with the four ART In-
charges, an open-ended thematic topic guide was de-
signed and used as the data collection instrument. The
instrument was designed to ensure that similar themes
and questions were covered in each interview. The in-
strument however had built-in flexibility that allowed for
any pertinent but unexpected issues that arose during
the individual interview process to be further probed.
The instruments focused on exploring nurse priscribers’
perspectives on HIV+ persons’ motivations for staying
on ART, the nature of barriers encountered in accessing
ART and how these barriers affected access to ART.
To ensure reliability, the study instruments were pre-
tested on HIV+ persons on ART who were not selected
for the actual study. The needed corrections and valida-
tions were done prior to the actual data collection.
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Data collection
The total number of respondents needed from a particular
study site was interviewed between May 5 – June 30 2014.
With the help of the ART Programme In-Charges, eligible
study participants were identified and interviewed using
paper-based questionnaires and topic guides. Interviews
were conducted by 8 research assistants (RAs), and super-
vised by the PI. Typically, each questionnaire interview
session took approximately 40 min, and participant’s
responses to questions were recorded on questionnaires.
In-depth interviews however lasted 40 - 60 min, and the
discussions were audio tape-recorded. In addition to con-
ducting interviews, the RAs also reviewed participants’
hospital records and relevant data were extracted.
The RAs were recruited from the University of Ghana’s
School of Public Health based on experience of conduct-
ing surveys and in-depth interviews as well as knowledge
of the local area. They were all trained. Training entailed
introduction to the study objectives, goals, methods and
expected outcomes. There were extensive role-plays to
ensure accuracy during data collection.
Data management and analysis
Data were reviewed daily for inconsistencies or omis-
sions and problems with data completion addressed.
Data collectors reviewed all completed data collection
forms and corrected any errors or inconsistencies before
hand-delivering them, along with their accompanying
consent forms to field supervisors. Supervisors also
reviewed the forms for accuracy, consistency, and com-
pletion. Once the data collection forms were considered
complete, they were securely delivered to the principal
investigator’s office where they were kept in locked filing
cabinets. All quantitative survey data were doubly en-
tered into pre-programmed data screens designed in
CSPro (Census and Survey Processing System) and
doubly entered at a centralised location at the PI’s insti-
tution. Data were exported to IBM SPSS Statistics, ver-
sion 20, for consistency checks and validation. Cleaned
and validated data sets were analysed using IBM SPSS
Statistics. Analyses of survey data were descriptive; we
used univariate analysis to generate descriptive tabula-
tions for key variables from the survey.
For the qualitative data, audio tape recordings of in-
depth interviews were transcribed and the data were the-
matically analysed. Results from the survey and in-depth
interviews were then brought together to illuminate the
barriers HIV+ persons face accessing ART in Ghana.
Results
Characteristic of study participants
A total of 540 questionnaires were returned after the
survey. Our unit of analysis is therefore 540. Table 1
shows the characteristics of the 540 ART clients who
completed the survey. The mean age of the study partic-
ipants was 42.3; age ranged from 18 to 65 years. Major-
ity (74.1%) of the participants were females.
The majority (42.9%) of the participants were also
married. Christians constituted 89.8% of the total sample,
while 20.1% of the participants had no formal education.
Also, majority (66.4%) of the participants were self-
employed farmers. Except 7.4% of the participants who
did not know how long they have been on ART, the length
of time most participants reported being on ART ranged
from 1 month to more than 11 years.
Desire and motivation to be on ART
Before examining the barriers PLH face accessing
ART, we first investigated participants’ desire and mo-
tivation to be on ART. Results from the survey sug-
gest that all (100%) the HIV+ persons interviewed
were already linked to ART. Findings from qualitative
open-ended questions embedded in the survey reveal
a number of reasons why all participants desire to be
on ART. These range from beliefs that ART will sup-
press the HIV virus, desire to maintain good health
and prolong life, and desire not to infect unborn chil-
dren, to desire to avoid death as well as desire to be-
come a good therapeutic citizen (abide by doctors’
advice). One female participant for example said: ‘I
want to be on ART because the ART will suppress the
HIV virus. This will help me maintain good health
and prolong my life’. One male participant also said: ‘I
want to be on ART…I take the drugs because I do not
want to die early. I take the drug to prolong my life
so as to be able to look after my children’. One other
female participant related why she was on ART and why
she wants to be on it: ‘Without ART, I would have been
dead by now. It keeps me alive. That is why I want to be
on it’. Another female participant said: ‘We are asked at
the counseling session to take our drugs…to take only the
doctor’s medicine. I do not want to disobey the doctor’.
One male participant also said: ‘I am on ART because I do
not want to infect my unborn child’.
Indeed, interviews with ART Programme In-charges
corroborated the accounts HIV+ persons gave. The ART
Programme In-Charge at the ART clinic at Korle Bu
hospital makes the point like this:
‘I think they [referring to ART clients] want to be on
ART because they do not want to joke with their lives.
They value their lives and some of them too when they
started coming to the ART clinic, the way they felt, the
way they were sick and how they have improved have
made them believe that indeed the ARVs work’.
The ART Programme In-Charge of the ART clinic at
Atua government hospital shared similar views:
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‘I think many of our clients are on ART and do want
to be on ART because they have realised the dangers
of not being on ART. Most of them have realised that
they can lead normal lives and be able to have children
who are HIV-free. So they are very motivated to come
for treatment’.
Most of the narrative accounts that both the HIV+
persons and ART Programme In-charges gave suggested
that most ART clients in the four study sites not only
recognise the dangers of not being on ART, but they also
recognise the benefits of being on ART. It is therefore
the recognition of dangers and benefits that co-mingled
to motivate most participants to stay on ART.
Barriers to accessing ART
Despite the fact that all the participants in this study
expressed a desire to receive and remain on ART, a
number of barriers were reported as hindering access to
ART. Table 2 shows a tabulation of responses to three
questions that asked participants to indicate three bar-
riers (in order of priority) they face accessing ART.
Seven main first priority barriers were reported by 63.3%
of all the study participants. These were delays associ-
ated with receiving care from treatment centres (10.9%),
long distance to treatment centres (1.1%), high financial
costs associated with accessing and receiving ART
(12.6%), job insecurity arising from regular leave of
absence to receive ART (2%), shortage of drugs and
other commodities (13.3%), fear of side effects of taking
ARVs (4.8%), and stigma (1.3%).
The percentage of participants reporting delays associ-
ated with receiving care from treatment centres, long
distance to treatment centres, high financial costs associ-
ated with accessing and receiving ART, job insecurity
arising from regular leave of absence to receive ART,




Atua Government Hospital 146 27.0
St Martin’s Martins de Porres Hospital 148 27.4
Tema General Hospital 93 17.2
Fevers Unit, Korle Bu Teaching Hospital 153 28.3
Region
Greater Accra Region 246 45.6













Religious affiliation of respondent









Postsecondary /Tertiary 36 6.7
Current Occupation
Unemployed 107 21.0
Self-employed Farmer 338 66.4









Table 1 Characteristic of study participants (n = 540 unless
indicated otherwise) (Continued)
HIV Disease State
HIV positive with no AIDS 365 67.6
HIV positive with AIDS 175 32.4
Number of years on ART
Don’t know 40 7.4




11 and above 13 2.5
CD4 Cell Count, median (range) 373 (2-1663.0)
Total 540 100
aMean age is 42.3; age ranged from 18 to 65 years
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shortage of drugs and other commodities, fear of side ef-
fects of taking ARVs, and stigma as second priority bar-
riers however decreased to 6.5, 4.5, 4.4, 1.3, 6.3, 1.5, and
1.1% respectively. These percentages, respectively, fur-
ther decreased to 1.7, 2, 3.5, 0.9, 2.2, 0.4, and 0.6% when
participants were asked to indicate their third priority
barrier. Crucially, 36.7% of the participants reported that
they did not face any barriers accessing ART when they
were asked to mention their first priority barrier. This
percentage, respectively, increased to 64.8 and 77.4%
when participants were asked to indicate their second
and third priority barriers.
Responses from the qualitative open-ended questions
embedded in the survey tools and the four ART
Programme In-charges illuminated the nature of some
of the barriers and the ways in which these barriers
acted to hinder access to ART for different categories of
HIV+ persons. In relation to the cost associated with
ART for example, many of the participants reported that
although government has subsidised the costs of ARVs,
the five Ghana cedis that they pay monthly to receive
ARVs was still not affordable, especially for those who
are not employed. Coupled with costs associated with
transportation as well as opportunity costs of travelling
to receive care, several participants, especially from rural
areas, reported that they are sometimes deterred from
seeking ART because of financial constraints. One female
participant makes the point thus:
‘I have challenges with paying for the drugs. We pay
monthly five cedis for the drugs; though this is not
much, I am unemployed and I do not have this
amount all the time. Also, because I come from the
village, I need money to pay for transportation. They
will refuse to give me the drugs too if I do not have the
money to pay. This is my number one challenge’.
Another female participant also related how delay
associated with receiving care from ART clinics was an
important barrier to ART access. ‘My major problem is
the long waiting time…sometimes we go early to the
clinic but you will come home very late. This makes me
feel reluctant to go sometimes’. Many of the participants
felt that they spend too much time waiting for the
needed services at each clinic visit. Delays at ART clinic
were reported to come from three main sources, namely
delay before folder is received, delay before seeing a
doctor/counselor, and delay at the pharmacy where med-
icines are dispensed. These delays were particularly con-
cerning for participants who are employed in the formal
sector, and who often need permission to absent them-
selves from work in order to attend ART clinic sessions.
As one participant said: ‘My boss does not want me out
of the factory for long during working hours’. Thus long
hours of absence from work was reported to breed job
insecurities as employers are more likely to replace
workers who frequently demand leave of absence. In-
deed, a number of participants made reference to HIV+
persons who had lost their jobs due partly to their HIV+
status, arising from regular requests for leave of absence
to seek treatment.
Others also spoke about how regular shortages of drugs
and other commodities such as nutritional supplements
often serve as disincentive for visiting ART clinics. One
male participant made the point like this:
The problem I have encountered is that sometimes I
will travel from my village to the clinic and they will
say there is no medicine or they will give me small
medicine and ask me to come the next week. You
know it is not easy to travel all this long distance.
Some participants also reported how fear of side ef-
fects and stigmatisation were major barriers to accessing
ART. ‘I experience some rashes on my skin which do not
allow me to come for medicine’. Participants who were
on ART for a relatively shorter time period before this
study, particularly reported side effects such as rashes.
Table 2 Barriers encountered in accessing ART
Barrier 1st Barrier 2nd Barrier 3rd Barrier Total
Freq % Freq % Freq % N
Delay before care is received 59 10.9 35 6.5 9 1.7 103
Long distance to treatment centres 6 1.1 24 4.5 11 2 41
Financial challenges 68 12.6 24 4.4 19 3.5 111
Job insecurity 14 2.6 7 1.3 5 0.9 26
No challenge 198 36.7 350 64.8 418 77.4 966
Shortage of drugs and other commodities 72 13.3 34 6.3 12 2.2 118
Fear of side effects 26 4.8 8 1.5 2 0.4 36
Stigmatisation 7 1.3 6 1.1 3 0.6 16
Total 540 100 540 100 540 100 1620
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Several of the narratives here suggested that the physical
manifestation of these side effects often triggered ques-
tions and suspicions from both family members and the
general public. In relation to stigma, one participant
said: ‘My heart beats faster whenever it is time for me to
go for ART…I am always afraid that I will meet someone
I know at the clinic…you know the stigma’. Thus fear of
being seen in an ART clinic by a known family member
or friend and the fear that one maybe stigmatised acted
as serious disincentives for HIV+ persons to access and
use ART services.
Results from in-depth interviews with the ART
Programme In-charges largely supported a number of
the barriers HIV+ persons reported. For instance, the
ART Programme In-Charge at the ART clinic at the St.
Martins de Porres hospital noted that:
‘Sometimes they [referring ART clients] are poor and
they don’t even have food to eat. How then can such
people pay for the transport and the small fees that
they are required to pay every month before receiving
treatment?’
The ART Programme In-Charge at the ART clinic at
Korle Bu hospital did not however think cost should be
a hindrance to accessing ART:
‘HIV treatment is basically free here. They [referring
to ART clients] don’t pay for consultation. The
medicines, they pay a token of GHS 5 a month. The
medicine itself is free but the GHS 5 a month is to
help the administrative work and even with that, now
they’ve introduced health insurance into it, so those
who have health insurance, it covers that GHS 5 so
they end up not paying and if you come and you don’t
have health insurance and GHS 5, you are still given
your medicine but the medicine you don’t pay for it.
So I don’t think cost should be a problem’.
This participant however acknowledged that periodic
shortage of drugs and basic consumables was a challenge.
‘At times there is shortage of drugs and when there is
shortage of drugs, it becomes a headache for us because
we don’t know what is going to happen to the patients.
We ourselves when there is shortage of drugs, test kits
and other things, it is very difficult for us to work’.
Discussion
This paper adds to the small but growing number of em-
pirical studies in the Ghanaian context that have
attempted to explore the barriers HIV+ persons face in
accessing ART. The paper reveals a number of findings
that should not be overlooked. The majority of our study
participants were either self-employed farmers (66.4%)
or unemployed (21%). Previous literature has highlighted
the causally-causative nature of the relationship between
poverty, unemployment and HIV/AIDS infection: that
poverty and unemployment could expose individuals to
risks of HIV/AIDS infection just as being HIV/AIDS
positive could trigger poverty and unemployment [23].
While our study did not set out to investigate this rela-
tionship, in-depth interviews with some participants in
this study suggested that in some cases, self-employment
and unemployment were themselves the product of HIV
+ persons losing their jobs in other viable sectors of the
economy due partly to their HIV+ status. Self-
employment in farming is an important livelihood activ-
ity in Ghana; but evidence from our qualitative in-depth
interviews suggested that most of the study participants
were subsistent farmers or were poor. This could poten-
tially limit the ability of such persons to generate and
accumulate sufficient stock of resources to be able to ac-
cess ART as well as meet their nutritional requirements.
This would suggest the need for targeted social and eco-
nomic safety net interventions such as conditional cash
transfer programmes and free or subsidised nutritional
supplementation interventions to support unemployed
and poor HIV+ persons to pay for HIV treatment costs
and meet their daily nutritional requirements. In the
context of Ghana more specifically, it might be beneficial
to include unemployed and poor PLH in current social
protection programmes such as the Livelihoods Empower-
ment Against Poverty (LEAP) programme.
Findings also revealed that 74% of the study’s partici-
pants were women. This statistic, we believe, is not the
result of sampling bias as both our examination of ART
clients’ hospital records and discussions with ART
Programmes In-charges suggested that, indeed, more
women than men are currently on ART in Ghana. We
believe this situation could potentially be explained by a
number of factors. Generally, the biological make-up of
women makes them more susceptible to HIV infection
than men. HIV is more readily transmitted from men to
women than women to men, with explanations related
to the larger surface area of the vagina and frequency of
tears during sexual intercourse [24]. While this bio-
logical vulnerability is indisputable, it has been recog-
nised that stressful factors such as social and economic
vulnerability of women in Africa often drive and sustain
patterns of unsafe sexual practices that place women at
risk of HIV [25]. This may partly explain why more
women are currently infected with HIV than men both in
Ghana and across the Sub-Saharan Africa region [25, 26].
This may in turn explain why more women than men are
on ART. Also, improved screening of women for HIV
during pregnancy in Ghana has meant that many more
HIV+ women are detected and enrolled on ART than
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men. Coupled with current levels of low counseling and
testing among men [27], it is plausible to think that more
women would dominate the list of ART clients. In
addition, HIV+ men have been found elsewhere to be less
willing to enroll on ART programmes partly because of
masculinity and gender role/identity conflicts and partly
because of shame and stigma [28, 29]. It is therefore pos-
sible that many HIV+ men in Ghana may be abstaining
from ART programmes for similar reasons. In this regard,
there may be the need for further research to understand
why more women than men are receiving HIV treatment
at ART clinics in Ghana. In the meantime, our findings
here would suggest the need for interventions to also
screen men as well as reach out to HIV+ men with avail-
able treatments.
All (100%) the HIV-positive persons interviewed in
this study were linked to ART. Consistent with previous
research elsewhere [29], we found that the reasons why
participants were on ART ranged from beliefs that ART
will suppress the HIV virus, desire to maintain good
health and prolong life, and desire not to infect unborn
children, to desire both to avoid death, and to become
good therapeutic citizens (abide by doctors’ advice). That
all participants recognised the benefits of ART and
wanted to be on ART clearly presents a golden oppor-
tunity for the government of Ghana, the Ghana Health
Service, healthcare providers and international partners
to build on this enthusiasm and initiate and/ or scale-up
programmatic and treatment interventions to reach all
HIV+ persons who need treatment. This could include
the provision of better and expanded screening services
especially to rural and hard-to-rich populations, the cre-
ation of more HIV treatment centres, and the resourcing
of such centres with trained professional caregivers and
essential commodities. Of course, given the limited fi-
nancial and human resources that are usually dedicated
to healthcare provisioning in Ghana, implementing these
recommendations can put additional pressure on the
healthcare system. However, the benefits of this additional
investment could be enormous as modest but effective
ART coverage has been shown to substantially reduce
morbidity and mortality related to HIV/AIDS infection as
well as HIV transmission risks [1–5].
Despite the fact that all the HIV-positive persons sam-
pled in this study were already linked to ART, 63.3% of
them reported experiencing at least one major barrier in
accessing ART. While the 36.7% who reported experien-
cing no challenge in accessing HIV treatment services is
an encouraging sign that Ghana is probably doing some
things right, the fact that majority of the ART clients are
experiencing challenges in accessing care must be cause
for concern. Among the first most important barriers
the participants in this study reported were delays asso-
ciated with receiving care from treatment centres
(10.9%), long distance to treatment centres (1.1%), high
financial costs associated with accessing and receiving
ART (12.6%), job insecurity arising from regular leave of
absence to receive ART (2%), shortage of drugs and
other commodities (13.3%), fear of side effects of taking
ARVs (4.8%), and stigma (1.3%). These barriers are very
similar to what has been documented in other previous
studies elsewhere [7, 14, 17–21] and in Ghana more
specifically [9, 11].
A substantial number of participants (10.9%) reported
delays associated with receiving care from treatment
centres as a major barrier. Delays came from long wait-
ing times before care was received. This long waiting
time is often the result of limited numbers of trained
healthcare personnel and ART centres. Compounding
the problem is the fact that only specific days in a month
are dedicated to all ART clients to receive care. The lack
of individualised booking system to receive care has
meant that large numbers of patients are brought to
treatment centres to receive care at the same time. Very
often, the limited healthcare staff at most of the treat-
ment centres is not able to promptly provide care to all
clients, leading to delays. As other researchers have
found, most clinics are under-resourced with long
waiting queues – all of which challenge the success in
retaining HIV patients in chronic care [5, 29, 30]. While
these delays are part of the realities of the healthcare
delivery systems in most resource limited settings and
may therefore not be unique to ART clinics, they are a
major disincentive for PLH to access ART. As a number
of our research participants reported, these delays are
very concerning for ART clients who are employed in
the formal sector, and who often require permission to
absent themselves from work in order to attend ART
clinic sessions. Therefore, spending long hours at
treatment centres instead of work places could offer
employers reasons to replace such employees. Our
findings here would therefore suggest the need for in-
terventions to address these delays and other related
barriers (see Table 3).
In addition to increasing the number of caregivers at
ART clinics, it might be helpful to design and institute
an individualised booking system whereby individual cli-
ents could choose different days during the month to at-
tend ART clinics. This could reduce the numbers of
ART clients seeking care at any particular point in time
to manageable sizes. This may reduce the overcrowding
and long waiting time that are currently associated with
ART clinics. The recommendations here are supported
by previous evidence from elsewhere that suggest that
increasing ART centres and health workforce can reduce
delays that are associated with receiving ART [12].
Several of the participants (12.6%) also reported cost
as a barrier to accessing care. While the current direct
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cost of ART in Ghana is relatively negligible, many HIV+
persons are still not able to afford to pay this cost and
other additional indirect costs. This is partly because
current approaches to providing care include multiple
clinic visits, which are costly for the patient in terms of
money and time. Consequently, patients who are poor
and lack resources for transport might opt to not attend
clinic. This could adversely affect adherence to treatment
and may cause relapse. In addition to the inclusion of
PLH in social and economic safety net programmes as we
have suggested above, the institutionalisation of a travel
costs reimbursement scheme might be useful. Elsewhere,
similar schemes have been reported to enhance access to
ART as well as increase ART adherence rates among HIV
+ persons [13]. In the context of Ghana, such a scheme
could be used to reimburse travel costs for ART clients,
especially those from rural areas who often travel long dis-
tances to access ART. Also, there is the need to generate
social support for ART clients at the levels of peers, family
and community. Such an intervention has been shown
to greater improve access to ART and as well enhance
adherence to ART [31]. In the context of Ghana, such
social support interventions could be modelled along
the lines of the directly observed treatment (DOTs)
methods which have been successfully used in the treat-
ment and management of tuberculosis (TB). As DOTs
has successfully been used in Ghana in the context of
TB, we believe a similar approach in the area of ART
has the potential to succeed.
Shortage of drugs and other commodities was also
reported as a major barrier to effective ART access. This
indeed is one of the major challenges confronting effect-
ive HIV/AIDS treatment across low- and middle-income
countries, and a number of researchers and policy docu-
ments have recently acknowledged it [4–7]. In the pres-
ence of shortage of ARVs and other essential
consumables, the full benefits of ART may not be rea-
lised. This would suggest the need for more resources to
be allocated to purchasing and stocking ART clinics with
sufficient quantities of essential medicines and commod-
ities. This should also be accompanied by strategies to
prevent waste and inefficiencies in the management
and use of medicines and essential commodities through
such practices as over prescription and corruption (e.g.
stealing or embezzlement of medicines from public
ART clinics for personal profit). Indeed, there is evi-
dence to suggest that countries that have made signifi-
cant progress in rolling out ART and reducing HIV
infection have done so with significant investment of
both human and financial resources [12, 13, 32]. Such
countries have also effectively prevented wastage, theft
of medicines and corruption in the management of
ART programmes [12, 13, 32].
Additional barriers that participants reported in-
cluded fear of side effects of taking ARVs and stigma.
We believe patient education on how to appropriately
administer medications as well as possible side effects
of different treatment regimen may help reduce both
the side effects of drugs and the fear that some pa-
tients harbour. Similarly, continues public education
and interventions to de-stigmatise HIV/AIDS and re-
duce stigma and discrimination against PLH may help
Table 3 Potential ways to address barriers encountered in accessing ART
Barrier Possible way(s) to address barrier
Delay before care is received - Establish more ART centres
- Train more caregivers
- Institute an individualised booking system so ART clients can choose different days
to receive care
Long distance to treatment centres - Establish more ART centres
- Implement occasional outreach programmes to care for ART clients
- Institute travel costs reimbursement schemes
- Create family, community, and peer support groups
Financial challenges - Establish targeted social and economic safety net interventions for HIV+ persons e.g.
conditional cash transfer programmes
- Include HIV+ persons, especially ART clients in LEAP programme
- Create family, community, and peer support groups
- Institute free/subsidised nutrition supplementation interventions
- Institute travel costs reimbursement schemes
Shortage of drugs and other commodities - Allocate more financial resources, especially financial resources to ART
- Prevent wastage in the use of drugs and other commodities
- Reduce inefficiencies in management and use of medicines
Fear of side effects - Educate ART client on how to properly administer medications
- Educate ART clients on possible side effects of different treatment regimens and how to
minimise potential side effects
Stigmatisation - Educate public on HIV/AIDS using both print and electronic media, including social media
- Institute anti-stigma interventions using community based and led strategies
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increase uptake of ART. As previous studies have
shown, both patient and public education can greatly
improve adherence to ART by reducing anxieties
about of side effects of ARVs as well as minimise
stigma against HIV+ persons [13, 20, 32].
Taken together, the findings presented in this paper
highlight an urgent need for interventions to address
different individual level and structural barriers to ART
access so as to optimise the full benefits of ART. The
findings and the accompanying recommendations
should however be read against the backdrop of certain
limitations. The research reported in this paper was
conducted at four ART clinics in southern Ghana.
Therefore, the limitation of applying the findings in
other parts of the country is acknowledged. This is
more so because HIV+ persons are not a homogenous
group, hence the perspectives of those interviewed in
this study might be different from what pertains else-
where in Ghana. In this regard, large-scale quantitative
and qualitative studies might be required to provide a
more holistic picture about the challenges HIV+ per-
sons face in accessing ART services at the national or
regional levels. Finally, there are a number of character-
istics not captured in the baseline demographics but
have been shown to be associated with access/ reten-
tion on ART. These include active illicit drug/ alcohol
use, mental illness, homelessness, viral load, type of
ART regimen prescribed and dosing, criminal justice
history, domestic and/ or interpersonal violence. These
limitations notwithstanding, important lessons can be
drawn from the findings in this paper to inform policies
and interventions that seek to promote greater access
to HIV/AIDS treatment for HIV+ persons. In particu-
lar, the results of the study provide useful pointers for
policymakers and healthcare providers within Ghana
and across the world to participate in designing innova-
tive interventions to redress the remaining barriers that
PLH face in accessing needed treatment.
Conclusions
Results from this study indicate that a number of struc-
tural and individual level barriers still act, alone or in con-
cert, to hinder HIV+ persons’ access to ART in Ghana,
even in situations where these services are available. Ef-
forts to provide and scale-up ART to all HIV+ persons
and ensure adherence must also be accompanied by inter-
ventions that address these remaining structural and indi-
vidual level access barriers. Among other interventions
(see Table 3), we recommend the institutionalisation of in-
dividual booking/appointment system of care, and a travel
reimbursement scheme for ART clients, more investment
to train more staff, purchase and stock ART clinics with
essential drugs and commodities as well as patient and
public education, to help address these challenges.
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